The Enterprise Value as of December 2025 (TTM) for Arovella Therapeutics Limited (ALA.AX) is 69.18M

According to Arovella Therapeutics Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 69.18M. This represents a change of -42.93% compared to the average of 121.22M of the last 4 quarters.

Arovella Therapeutics Limited (ALA.AX) Historical Enterprise Value (quarterly & annually)

How has ALA.AX Enterprise Value performed in the past?

The mean historical Enterprise Value of Arovella Therapeutics Limited over the last ten years is 32.19M. The current 69.18M Enterprise Value has changed 21.39% with respect to the historical average. Over the past ten years (40 quarters), ALA.AX's Enterprise Value was at its highest in in the December 2024 quarter at 167.48M. The Enterprise Value was at its lowest in in the June 2011 quarter at -2366884.00.

Arovella Therapeutics Limited (ALA.AX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Arovella Therapeutics Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Arovella Therapeutics Limited (ALA.AX) Average Enterprise Value

How has ALA.AX Enterprise Value performed in the past?

The current Enterprise Value of Arovella Therapeutics Limited (ALA.AX) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Arovella Therapeutics Limited (ALA.AX) Enterprise Value vs. Peers

How is ALA.AX’s Enterprise Value compared to its peers?

Arovella Therapeutics Limited’s Enterprise Value is less than Island Pharmaceuticals Limited (107.78M), greater than Alterity Therapeutics Limited (58.48M), less than Imugene Limited (83.96M), less than Actinogen Medical Limited (164.97M), less than Recce Pharmaceuticals Ltd (166.60M), greater than EZZ Life Science Holdings Limited (52.10M), less than Biome Australia Limited (86.93M), greater than Amplia Therapeutics Limited (55.85M), less than Alcidion Group Limited (124.72M), greater than PainChek Limited (64.16M),

Build a custom stock screener for Arovella Therapeutics Limited (ALA.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arovella Therapeutics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Arovella Therapeutics Limited (ALA.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Arovella Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.